Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma.

Li, Xing

Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma. [electronic resource] - Leukemia & lymphoma Sep 2010 - 1678-85 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1029-2403

10.3109/10428194.2010.499486 doi


Acute Disease
Adult
Aged
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Antiviral Agents--therapeutic use
Bilirubin--metabolism
Cyclophosphamide--administration & dosage
DNA, Viral--genetics
Doxorubicin--administration & dosage
Female
Follow-Up Studies
Hepatitis B--drug therapy
Hepatitis B virus--physiology
Humans
Liver Function Tests
Lymphoma, B-Cell, Marginal Zone--virology
Lymphoma, Follicular--virology
Lymphoma, Large B-Cell, Diffuse--virology
Male
Middle Aged
Polymerase Chain Reaction
Prednisone--administration & dosage
Prognosis
Prothrombin Time
Rituximab
Survival Rate
Vincristine--administration & dosage
Virus Activation--drug effects